Brian C.KellerMDPhD(He/Him)
Pulmonology • Boston, MACritical Care Medicine, Lung Transplantation Medicine
Member of the Faculty
Dr. Keller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Pulmonary & Critical Care
55 Fruit Street, Bulfinch 148
Boston, MA 02114Phone+1 617-726-8854
Summary
- Dr. Brian C. Keller is Medical Director of Lung Transplantation at Massachusetts General Hospital in Boston, MA. He received his medical degree from the University of Texas Southwestern Medical School and completed Residency in Internal Medicine and Fellowship in Pulmonary & Critical Care Medicine at Washington University in St. Louis. Dr. Keller specializes in the care of patients with end-stage lung disease, lung transplantation, critical care medicine, and bronchoscopy. He is also a successful physician-scientist with experience leading a lung transplant biorepository and a number of clinical trials and translational studies focused on improving outcomes after lung transplantation.
Education & Training
Washington University in St. Louis School of MedicinePost-Doctoral Fellowship, 2014 - 2015- Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2009 - 2011
U of TX SW Med Ctr at Dallas, Graduate School of Biomedical SciencesPhD, Microbiology, 2001 - 2009
University of Texas Southwestern Medical SchoolClass of 2009
Certifications & Licensure
MA State Medical License 2022 - 2026
OH State Medical License 2015 - 2022
MO State Medical License 2010 - 2016- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 398 citationsEnrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.Leopoldo N. Segal, Jose C. Clemente, Jun Chieh J. Tsay, Sergei B. Koralov, Brian C. Keller
Nature Microbiology. 2016-04-04 - 324 citationsSystematic Determination of the Packaging Limit of Lentiviral VectorsMukesh Kumar, Brian C. Keller, Ndeye Makalou, Richard E. Sutton
Human Gene Therapy. 2001-10-10 - 20 citationsTrends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era.Christopher M Bobba, Bryan A Whitson, Matthew C Henn, Nahush A Mokadam, Brian C Keller
Transplant International. 2022-01-01
Grant Support
- NIH Loan Repayment Program, RenewalNHLBI2016–2018
- NIH Loan Repayment ProgramNHLBI2014–2016
- Washington University Institute of Clinical and Translational Sciences Pilot AwardNIH/NCATS2014–2015
- Ruth L. Kirchstein NRSA Institutional Training GrantNational Heart, Lung, and Blood Institute2013–2015
Professional Memberships
- The International Society for Heart and Lung TransplantationAssociate Member
- Trainee Member
- Member
- Member
- European Respiratory SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
